Lexicon Pharmaceuticals's top three insider shareholders as of May 04, 2026 are International S.C.A. Artal (Director, 136.18Mn shares), International S.C.A. Artal (Director, 136.18Mn shares), International S.C.A. Artal (Director, 136.18Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| International S.C.A. Artal | - | 0 | 136,180,481 | 14 May, 2024 |
| International S.C.A. Artal | - | 0 | 136,180,481 | 14 May, 2024 |
| International S.C.A. Artal | - | 0 | 136,180,481 | 14 May, 2024 |
| Us Partners Llc Invus | - | 0 | 5,451,204 | 09 Aug, 2022 |
| Us Partners Llc Invus | - | 0 | 5,451,204 | 09 Aug, 2022 |
| Us Partners Llc Invus | - | 0 | 5,451,204 | 09 Aug, 2022 |
| Us Partners Llc Invus | - | 0 | 5,451,204 | 09 Aug, 2022 |
| Raymond Debbane | - | 0 | 5,303,814 | 01 Aug, 2022 |
| Raymond Debbane | - | 1,906,186 | 0 | 27 Feb, 2026 |
| Global Management, Llc Invus | - | 0 | 1,538,462 | 04 Feb, 2026 |
| Global Management, Llc Invus | - | 0 | 1,538,462 | 04 Feb, 2026 |
| Global Management, Llc Invus | - | 0 | 1,538,462 | 04 Feb, 2026 |
| International S.C.A. Artal | - | 0 | 1,150,922 | 13 Mar, 2024 |
| International S.C.A. Artal | - | 0 | 1,150,922 | 13 Mar, 2024 |
| International S.C.A. Artal | - | 0 | 1,150,922 | 13 Mar, 2024 |
| Lonnel Coats | Chief Executive Officer | 1,098,068 | 0 | 29 Feb, 2024 |
| Brian T Crum | Svp, General Counsel Secr. | 428,802 | 0 | 03 Mar, 2026 |
| Participations S.A R.L. Artal | - | 0 | 408,435 | 19 Feb, 2026 |
| Participations S.A R.L. Artal | - | 0 | 408,435 | 19 Feb, 2026 |
| Participations S.A R.L. Artal | - | 0 | 408,435 | 19 Feb, 2026 |
| Global Management, Llc Invus | - | 0 | 367,145 | 04 Feb, 2026 |
| Global Management, Llc Invus | - | 0 | 367,145 | 04 Feb, 2026 |
| Global Management, Llc Invus | - | 0 | 367,145 | 04 Feb, 2026 |
| Alan J Main | Evp, Innov Chem Sciences | 339,104 | 0 | 03 Mar, 2025 |
| Jeffrey L Wade | President And Cfo | 324,214 | 0 | 29 Feb, 2024 |
| Craig B Granowitz | Svp, Chief Medical Officer | 323,430 | 0 | 03 Mar, 2026 |
| Michael Exton | Chief Executive Officer | 298,432 | 0 | 03 Mar, 2026 |
| Philippe Amouyal | - | 285,174 | 0 | 13 May, 2025 |
| Wendy Mcdermott | Svp, Human Resources | 277,945 | 0 | 03 Mar, 2026 |
| Kenneth B. Kassler-Taub | Svp, Regulatory Qa | 162,672 | 0 | 29 Feb, 2024 |
| Suma Gopinathan | Svp, Discovery | 150,132 | 0 | 03 Mar, 2026 |
| Sam L Barker | - | 124,459 | 0 | 13 May, 2025 |
| Scott M Coiante | Svp, Chief Financial Officer | 105,356 | 0 | 03 Mar, 2026 |
| Lisa Defrancesco | Svp, Ir And Corp Comm | 93,869 | 0 | 03 Mar, 2026 |
| Judith L Swain | - | 85,174 | 0 | 13 May, 2025 |
| Kristen Alexander | Vp, Finance And Accounting | 76,368 | 0 | 03 Mar, 2025 |
| Kiernan Seth | Vp, Chief Commercial Officer | 53,136 | 0 | 01 Mar, 2023 |
| Robert J Md Lefkowitz | - | 48,364 | 0 | 29 Apr, 2024 |
| Alan S Nies | - | 41,046 | 0 | 22 May, 2023 |
| Rachel Yap Martens | Svp, Partnerships Corp Strat | 31,264 | 0 | 03 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 28 Feb, 2026 | Rachel Yap Martens | Common Stock | A | 67,090 | - | 67,090 | D | M |
| 28 Feb, 2026 | Suma Gopinathan | Common Stock | A | 14,000 | - | 88,520 | D | M |
| 28 Feb, 2026 | Wendy Mcdermott | Common Stock | A | 27,697 | - | 149,343 | D | M |
| 28 Feb, 2026 | Brian T Crum | Common Stock | A | 33,457 | - | 363,658 | D | M |
| 28 Feb, 2026 | Lisa Defrancesco | Common Stock | A | 24,674 | - | 40,251 | D | M |
| 28 Feb, 2026 | Craig B Granowitz | Common Stock | A | 35,790 | - | 156,042 | D | M |
| 28 Feb, 2026 | Michael Exton | Common Stock | A | 503,263 | - | 503,263 | D | M |
| 28 Feb, 2026 | Scott M Coiante | Common Stock | A | 160,237 | - | 160,237 | D | M |
| 28 Feb, 2026 | Michael Exton | Common Stock | D | 204,831 | $1.47 | 298,432 | D | F |
| 28 Feb, 2026 | Craig B Granowitz | Common Stock | A | 74,226 | - | 230,268 | D | M |
| 28 Feb, 2026 | Lisa Defrancesco | Common Stock | A | 128,190 | - | 168,441 | D | M |
| 28 Feb, 2026 | Suma Gopinathan | Common Stock | A | 20,310 | - | 108,830 | D | M |
| 28 Feb, 2026 | Rachel Yap Martens | Common Stock | D | 35,826 | $1.47 | 31,264 | D | F |
| 28 Feb, 2026 | Wendy Mcdermott | Common Stock | A | 52,316 | - | 201,659 | D | M |
| 28 Feb, 2026 | Brian T Crum | Common Stock | A | 69,386 | - | 330,201 | D | M |
| 28 Feb, 2026 | Scott M Coiante | Common Stock | D | 54,881 | $1.47 | 105,356 | D | F |
| 28 Feb, 2026 | Rachel Yap Martens | Restricted Stock Units | D | 67,090 | - | 134,180 | D | M |
| 28 Feb, 2026 | Craig B Granowitz | Common Stock | A | 202,260 | - | 432,528 | D | M |
| 28 Feb, 2026 | Lisa Defrancesco | Common Stock | D | 74,572 | $1.47 | 93,869 | D | F |
| 28 Feb, 2026 | Scott M Coiante | Restricted Stock Units | D | 160,237 | - | 320,473 | D | M |